AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Diclofenac Sodium; Misoprostol in Nigeria
9 products registered with NAFDAC — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Bosstotec Tablets Tablet | A4-101217 | ZMC International Limited | active | 26 Mar 2030 |
| Zymthrotec Tablets** Tablet | A4-101039 | ZMC International Limited | active | 24 Sept 2029 |
| Resthrotec Tablets** Tablet | A4-100895 | Restore Healthcare Ltd | active | 26 Jun 2029 |
| Osteotec Tablets Tablet | A4-100764 | BochePharm Nigeria Limited | active | 27 Feb 2029 |
| Rostrec 75 Tablets Tablet | A4-100577 | Visko Pharmacy Ltd | active | 30 Oct 2028 |
| Diprostol Tablet 50 mg + 200 mcg Tablet | B4-5447 | Nurushat Ventures Limited | active | 26 Jul 2028 |
| Zytrotec 75 mg/200 mcg Tablet** Tablet | B4-5893 | Malven Medics International Company Ltd | active | 27 Mar 2028 |
| Eprotec Tablet Tablet | A11-100340 | Zolon Healthcare Limited | active | 15 Dec 2026 |
| Arthrotec 75 Tablets** Tablet | A4-3491 | Pfizer Specialties Ltd | active | 29 Nov 2025 |
Diclofenac Sodium; Misoprostol — NAFDAC Registration Details
NAFDAC (Nigeria) has 9 registered products containing Diclofenac Sodium; Misoprostol, of which 9 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Diclofenac Sodium; Misoprostol registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.